Keynote Speaker  
Jennifer French, executive director, STIM Society
Jennifer French is executive director of the Society to Increase Mobility (STIM), a nonprofit organization founded in Florida in 2003. Jennifer acquired her C6-7 incomplete spinal cord injury in 1998. Prior to her injury, she was recreationally active with such sports as canoeing, snowboarding/skiing, sailing, fly fishing, biking. After her injury, she still participates in all those activities. She is an active user of an FES system. Now residing in Tampa, Florida, Jen is active in the community accessible sailing program, Sailing Alternatives as well as the national US Sailing, Sailors with Special Needs. French has helped launch successful divisions is such organizations as Bombardier Capital and PC Connection, Inc. With an MBA specializing in marketing & strategy, she works with for-profit and not-for-profit organizations, large and small, emerge into new markets, profile target customers and create and build systems to support sales efforts. She is currently freelancing her talents through TJF Consulting, Inc.
Neurotech Reports Editors  
James Cavuoto, editor and publisher
James Cavuoto is editor and publisher of Neurotech Business Report and the founder of Neurotech Reports. He was the lead author of "The Market for Neurotechnology," a market research report published by Neurotech Reports. Cavuoto was the founder of Micro Publishing Press, Inc., a publishing company that helped pioneer the market for electronic publishing, digital imaging, and computer graphics. He holds a degree in biomedical engineering from Case Western Reserve University, where he studied under pioneers in the new field of functional electrical stimulation. He has also studied human factors engineering at University of Southern California in Los Angeles. Cavuoto spent three years as a member of the technical staff at Hughes Aircraft Company in Los Angeles, where he worked on simulation, training, and publication products produced for the U.S. Department of Defense. Cavuoto is an adjunct professor of publishing at Rochester Institute of Technology and the author of eight books on computer graphics, electronic publishing, and digital imaging. He is a member of the IEEE Engineering in Medicine and Biology Society.

Warren Grill, Ph.D., senior technology editor
Warren M. Grill is one of the nation's leading experts in neural stimulation and neural prostheses. Dr. Grill is Associate Professor of Biomedical Engineering at Case Western Reserve University and a Principal Investigator at the Cleveland FES Center. He is a founding member of the International Functional Electrical Stimulation Society and serves on the editorial board of Neuromodulation and as Associate Editor of the IEEE Transactions on Neural Systems and Rehabilitation Engineering. He has authored 35 peer-reviewed publications and is holder of five patents.

Glenn Cornett, M.D., Ph.D., senior financial editor
Glenn Cornett is an experienced neuroscientist, entrepreneur, and financial consultant, with a background in research and business development. After earning his Ph.D. in neuroscience from UCLA and his M.D. from University of Michigan Medical School, Glenn spent several years as a technology and healthcare consultant with McKinsey & Company. He has also held marketing and business development positions at Lilly & Company and Razorfish. He currently runs his own consulting firm, Metastrat, in Palo Alto, CA, providing strategic advisory services to biotechnology and medical device firms.

Konstantinos Alataris, PhD, Bay City Capital
Konstantinos Alataris is an Associate at Bay City Capital in San Francisco, focusing on investment and strategic advisory services. Dr. Alataris was previously a Business Development Manager with Compass, Guidant's Corporate Venturing Group, where he analyzed and structured medical device/healthcare investments and evaluated acquisition targets. He was also a Research Fellow at the House Ear Institute, a research center and clinic in Los Angeles. Dr. Alataris holds a Ph.D. in Biomedical Engineering, an MBA, and an M.S. in Electrical Engineering from the University of Southern California. He received a BS in Electrical Engineering and Computer Science from the National Technical University of Athens, Greece.
Roger Quy, Ph.D., Technology Partners
Roger Quy is partner with Technology Partners. He joined Technology Partners in 1989, where he has been responsible for building the life science practice of the firm. Previously, he led an artificial intelligence research group at Hewlett Packard Laboratories. Prior to that, he managed the development of medical devices at Oxford Instruments Group in England. He is a Director of several private companies including InnerCool Therapies, Rinat Neuroscience, and Spinal Dynamics. Roger began his career as a post-doctoral Research Fellow of the Medical Research Council at the Institute of Neurology in London, where he developed new techniques and devices for the diagnosis and treatment of neurological, cardiac and sleep disorders. He has published a number of scientific papers and contributed to a textbook on epilepsy. He has four patents issued and one pending. Roger earned a BA with honors in psychology and law and a Ph.D. in neuroscience from the University of Keele, England. He received an MBA from the Haas School of Business at the University of California, Berkeley.
Heath Lukatch, Ph.D., Piper Jaffray Ventures
Heath Lukatch is managing director with Piper Jaffray Ventures, a venture capital firm in San Francisco. Heath focuses on emerging companies in the biotechnology and medical technologies sectors. Prior to joining Piper Jaffray Ventures in January 2001, Heath was an Engagement Manager in McKinsey & Company's San Francisco Office where he focused on the biotechnology and genomics industries. Prior to McKinsey, he was co-founder and CEO of AutoMate Scientific, a biotechnology instrumention company, and he held scientific positions with Chiron Corporation and Roche Bioscience. Heath received his Ph.D. in Neuroscience from Stanford University and his B.A. in Biochemistry from the University of California at Berkeley.
Daniel O'Connell, NeuroVentures Fund
Daniel O'Connell is a Director of NeuroVentures Fund LP, a venture capital firm specializing in the neuroscience field. Mr. O’Connell originally worked with founding members of NeuroVentures to launch the Fund while he was attending business school. In 2000, he joined as a Director. In addition to his experience at NeuroVentures, Mr. O’Connell’s involvement with venture-stage medical technology companies includes co-founding MedSpecialists, Inc., a clinical ASP for medical specialists, and Surgical Solutions, LLC, a company dedicated to commercializing innovative neurosurgical products from leading research universities. Prior to business school, Mr. O’Connell spent four years in investment banking with Advest, Inc. He holds a B.A. from Brown University and M.B.A. from the University of Virginia.

Gerald Loeb, M.D., Ph.D., AMI/University of Southern California
Gerald Loeb is professor of biomedical engineering at the University of Southern California and director of the medical device development facility at the Alfred Mann Institute for Biomedical Engineering at USC. Dr. Loeb received his M.D. from Johns Hopkins University, and trained in surgery at the University of Arizona. He spent 15 years in the Laboratory of Neural Control at the National Institutes of Health and 12 years at Queen's University where he was professor of physiology and director of the Bio-Medical Engineering Unit. He was one of the developers of the cochlear implant now used to restore functional hearing to the deaf and continues to pursue improvements in this mature technology. He serves as Chief Scientist (consulting) for Advanced Bionics Corp. of Sylmar, California. Dr. Loeb has published over 150 journal articles, a book on electromyography, and holds 18 patents.

Yitzhak Zilberman, Ph.D., Alfred Mann Foundation
Yitzhak Zilberman is vice president, business development with the Alfred Mann Foundation (AMF) in Valencia, CA. He has conceived and leads BionTech(tm), a collaborative R&D program aimed at developing clinical applications based on the BION(r) microstimulator. Prior to joining AMF, Yitzhak held various managerial positions at MiniMed, Advanced Bionics Corp. and its European subsidiary, Advanced Bionics SARL. Yitzhak also has been consulting for various Alfred Mann companies including Quallion, Medical Research Products and Second Sight. He holds degrees in Computer Science and Archeology and is a graduate of the UCLA Anderson School Executive Program. Yitzhak served 14 years as an officer in the Israeli Defense Forces Intelligence Corps, during which he won the Israel Defense Award, Israel's most prestigious recognition for research and development.
Chris Berka, CEO, Advanced Brain Monitoring, Inc.
Chris Berka has over 22 years experience managing clinical research and developing and commercializing new technologies. She is Chief Executive Officer and co-founder of Advanced Brain Monitoring, Inc., (ABM) a Carlsbad, CA company that develops data acquisition technologies that enable the creation of low cost, easy-to-use, portable systems that monitor and interpret physiological signals, including the brain's electrical activity (EEG). She is co-inventor of three patented and two patent-pending technologies and is the principal investigator or co-investigator for grants awarded by the National Institutes of Health and the Defense Advanced Research Projects Agency that provide more than $6 million of research funds to ABM. Ms. Berka has 10 years experience as a research scientist with publications on the analysis of EEG in patients with sleep and neurological disorders. She received her B.A. with distinction in Psychology/Biology at Ohio State University and completed graduate studies in Neuroscience at the University of California, San Diego.

Alan Gevins, Ph.D., SAM Technology
Alan Gevins first began working on measuring cognitive brain function as an undergraduate at MIT. He says it was a harder problem than he first thought. He is the founder (in 1981) and Executive Director of the San Francisco Brain Research Institute and the founder (in 1986) and President of SAM Technology, both in San Francisco. Prior to that, he was the Director of the EEG Systems Laboratory at UCSF. Dr. Gevins is internationally known for developing algorithms and systems for analyzing human brain function, and for basic science studies of cognitive brain function. He is the author of over 150 scientific papers and of 16 U.S. patents. His research is currently supported by seven NIH institutes, the Office of Naval Research, and DARPA.

Robert Pickar, TechMarket Research
Robert Pickar is a consultant specializing in technical marketing and product management for medical technology firms. He has performed contract work for the Alfred Mann Institute at University of Southern California, Eradlink, General Elctric Medical Systens, and Ecliptic Enterprises, Inc. He received an M.Sci. from Columbia University & Columbia-Presbyterian Medical Center, in New York, NY, an M.S. from Columbia University, School of Engineering and Applied Sciences, in Optics & Lasers, and a B.S. in Physics from the University of California, San Diego.

Philip Kennedy, M.D., Ph.D., Neural Signals Inc.
Philip Kennedy is the president and founder of Neural Signals, Inc., and a pioneer in the field of brain computer interfaces. He also holds an appointment in the department of neurology at Emory University medical school in Atlanta, GA. Dr. Kennedy received the Discover Award for technical innovation in assistive technologies in June 1999 and the World Technology Award for health and medicine in 2000 for inventing the neurotrophic electrode. He received his medical degree from the National University of Ireland.

Luncheon Speaker  
Paul Beach, Quallion, LLC
Paul Beach is the Director of Business Development and General Counsel of Quallion LLC, a Los Angeles based company developing custom-made lithium ion rechargeable batteries. Mr. Beach leads Quallion's efforts to penetrate new markets and expand opportunities in its existing space. Mr. Beach has over seven years of experience working with varied technologies, including hybrid disk drives, Internet based business applications, and bioinformatics. Prior to coming to Quallion, Mr. Beach served as General Counsel and Vice-President of Business Development for Infoloan, Inc., a Silicon Valley based online mortgage broker with an emphasis in the Chinese market. Mr. Beach assisted in launching Infoloan in Hong Kong and Taiwan as well as expanding operations domestically. Before joining Infoloan, Mr. Beach served as an attorney with Taylor & Co. Law Offices in San Francisco, CA. Clients included PeopleSoft Software and TeraStor Corporation.
Entrepreneur Panel  
Alan Olsen, CEO, Robomedica, Inc.
Alan Olsen has been an independent business consultant for the past eight years and serves on the board of several public, private and charitable organizations. Mr. Olsen has over 28 years of medical device sales and marketing experience at Smith & Nephew Richards, Danek Medical, and Sofamor Danek Group. He was founder and President of Danek Medical, a pioneer in the spinal fixation device market, which later became part of Sofamore Danek Group. He served as a Director of Sofamor Danek Group from 1985 to 1993.
Timothy Surgenor, President and CEO, Cyberkinetics, Inc.
Timothy Surgenor joined Cyberkinetics, Inc. as President and CEO in January 2003, after serving as Executive Vice President of Haemonetics Corp., a company commercializing automated blood processing systems, where he was responsible for global marketing, business development, regulatory, affairs and quality assurance. While at Haemonetics, Surgenor significantly strengthened the company’s product portfolio and grew revenues by focusing internal development programs and by completing several technology acquisitions. Prior to Haemonetics, Surgenor was a Division President and Senior Executive of Genzyme Corp. At Genzyme, Surgenor led the development of several key cell therapy programs, which are now incorporated in the Genzyme BioSurgery division. Mr. Surgenor has an MBA from Harvard University and an undergraduate degree from Williams College.

Jason Harry, Ph.D., CEO, Afferent Corp.
Jason Harry has worked in biomedical engineering and medical device entrepreneurial environments for over 20 years. Prior to founding and capitalizing Afferent in 2000, he was VP of Research Engineering at NMT Medical, Boston, MA, a company specializing in minimally invasive cardiovascular implants. Having joined NMT in 1994 as its fifth employee, he built the infrastructure and team responsible for new product development. He led due diligence efforts on product and company acquisitions, and managed technology transfer with corporate partners. He received his doctorate from Harvard University in 1988 and was on the faculty of Brown University for five years, where his research focus was functional neural stimulation and muscle mechanics.
Scott Corbett, President and CEO, Advanced Cochlear Systems
Scott Corbett is president, CEO, and co-founder of Advanced Cochlear Systems. He has been active in the biomedical field for over 20 years as an entrepreneur and technologist. He is the former president of PI Medical (now MicroHelix), former vice president of R&D for Precision Interconnect (now a Tyco International Ltd. Healthcare Group) and a former Advanced Development Engineer with GE Medical Systems, Ultrasound Division. He is also a co-founder of MicroConnex, Inc. Mr. Corbett's expertise includes high-density micro-fabricated electrodes, acoustics, signal processing and biomedical packaging. Mr. Corbett has an undergraduate degree in Physics from Occidental College and a Master's degree in Acoustics from Penn State University.
Lee Cuthbert, President, Intelli-Scents
Lee Cuthbert is the president and chief innovation officer of Intelli-Scents, a scent technology firm in San Francisco, CA. In addition to commercializing a new invention in the fragrance and scent sampling field, he has also served as vice president of business development for CPI Labs, which creates and produces scented personal care and household products for specialty retailers. Previously, he was vice president of business development at ScentAir Technologies, which markets an environmental scent device for use in a wide variety of retail applications. Lee also ran business development for Emerging Technologies at DigiScents, Inc, a digital scent technology company in the Bay Area. Lee co-founded Coinstar, a publicly traded company that owns and operates a network of interactive self-service kiosks located in major supermarkets that convert consumer's coins into cash. He received a BA from Colgate University and an MBA from the Harvard Graduate School of Business Administration.
Jamal Fakhoury, DC, Director of Regulatory Affairs,
Cyclotec Medical Industries, Inc.

Jamal Fakhoury is a board-certified chiropractic orthopedist with a Masters Certification from the San Diego Spinal Research Institute. He has practiced in the State of Florida for the past 20 years. Dr. Fakhoury is director of two Florida clinical treatment centers with six resident physicians in Ocala and Crystal River. His primary clinical practice consists of traumatic injuries, many of which require Cyclotec's CT1 TENS applications. Dr Fakhoury serves as the First Vice President on the American College of Chiropractic Orthopedics, and is very involved in dedicating time to charitable organizations within his community. Dr Fakhoury serves both as vice president of Cyclotec's Board of Directors and Chairman of Cyclotec's Advisory Board.
Stephen Michleson, CEO, Cyclotec Medical Industries, Inc.
Stephen Michelson is the CEO and founder of Cyclotec Medical Industries, Inc. He has extensive and relevant experience in the cross disciplines of pharmacology, orthotics, and electrotherapy. Mr. Michelson has developed products in both the Splint and TENS industries, focusing on innovative concepts for non-invasive acute pain care. In 1964, Mr. Michelson founded All Orthopedic Appliances, Inc. (AOA) and began for the first time the design, production, and distribution of 'quick (applied) splints' with Velcro. He served as Chairman and CEO of AOA, managing 300 employees in three plants located in Florida, Oklahoma, and California. From 1964 to 1975, over 160 new products were developed and marketed. AOA was sold to the Parke Davis Medical-Surgical Division of Warner Lambert Corp. in 1975. In 1978, Mr. Michelson founded Cyclotechnical Medical Industries, Inc. (CMI), and organized a team of physicians and engineers to investigate the efficacy of combining simplified low cost electrostimulation devices for the management of acute pain. CMI ultimately licensed patents and proprietary TENS Pain Suppression technology to Dow Corning Wright Corp.



site design by shalatdesign | shalat.com